A Breakthrough in Vaccine Delivery In a revolutionary shift from conventional immunization methods, scientists at Tokyo Medical and Dental University's Uchida Laboratory, along with various prestigious institutions, have created a "naked" mRNA vaccine for SARS-CoV-2. This
In a decisive move to safeguard financial stability and bolster public trust, the United States government has announced a significant intervention in the wake of the Silicon Valley Bank (SVB) failure. Unprecedented Access to Depositor Funds Starting on Monday, former clients of SVB are assured
To escalate the war on cancer, Sutro Biopharma has launched a public offering with the goal of raising $75 million. These proceeds are set to bolster Sutro's efforts in creating cutting-edge antibody-drug conjugates (ADCs), which stand at the forefront of its cancer treatment research. By
Strategic Financial Undertaking by Matinas BioPharma Matinas BioPharma Holdings, Inc. has embarked on a crucial growth plan with its recent $10 million direct offering. Such a financial move is a testament to the company's dedication to securing necessary capital for advancement. The offering
Global clinical research adheres to an intricate framework of laws and regulations, challenging organizations and researchers to remain in compliance. With the rise of the GDPR, understanding and navigating the complexities of international data privacy is now an integral part of conducting
Rabies continues to pose a major public health issue worldwide, but YS Biopharma is breaking new ground with its PIKA Rabies Vaccine. This vaccine has delivered promising results during its Phase III clinical trials. The innovation lies in the company's unique PIKA adjuvant technology, which
